ANNX vs SNDX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ANNX · Annexon$4.20 ▲ 4.87%
SNDX · Syndax Pharmaceuticals$9.54 ▲ 1.81%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ANNX +40.9%
- SNDX -39.3%
Head to head
| Metric | ANNX | SNDX |
|---|---|---|
| Price | $4.20 | $9.54 |
| Change today | ▲ 4.87% | ▲ 1.81% |
| Market cap | $796.23M | $858.87M |
| Return, 3 months | -22.1% | -53.2% |
| Return, year to date | -16.3% | -54.6% |
| Return, 1 year | +45.8% | -36.6% |
| P/E (TTM) | – | – |
| P/B | 4.3 | -49.9 |
| P/E percentile vs own 5y | 33rd | 56th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +91.8% |
| Net profit growth (YoY) | -12.6% | +31.3% |
| Gross margin | – | 95.8% |
| Operating margin | – | -77.0% |
| Net margin | – | -87.5% |
| Return on equity | -104.3% | -255.9% |
| Analyst target vs. price | +324.5% | +301.4% |
| Analyst buy share | 86% | 100% |
| RSI (14) | 55 | 26 |
| 30-day volatility | 76.8% | 114.7% |
| Max drawdown, 1 year | -51.0% | -62.7% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SNDX is the largest of the group by market value.
- ANNX has returned the most over the past year.
- ANNX has been the calmest stock over the last 30 days.